Previous 10 | Next 10 |
PR Newswire news releases related Pr Newswire news releases and Pr Newswire press releases from 11/13/19 04:05:00 on US and Canada Markets.
SAN DIEGO , Nov. 13, 2019 /PRNewswire/ -- Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of cancer patients, reports financial results for the three and n...
Q1 Results: 1 Revenue : $13.2 billion Growth of 2% year over year Earnings per Share: GAAP: $0.68 ; Non-GAAP: $0.84 Non-GAAP EPS increased 12% year over year Q2 Guidance: Revenue: (3)% to (5)% decline year over year Earnings per Share: GAAP: $0.61 to ...
SAN DIEGO , Nov. 13, 2019 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs, today announced that Bar...
PARK CITY, Utah , Nov. 13, 2019 /PRNewswire/ -- MMA Energy Capital (the "Company"), a leading provider of capital in the renewable energy space, today announced that it has reached over $2 billion in originations of renewable energy investments. Since 2015, the Company has originat...
TUCSON, Ariz. , Nov. 13, 2019 /PRNewswire/ -- AudioEye, Inc. (NASDAQ: AEYE ) , a leading developer of digital accessibility solutions that provide barrier-free website access for individuals with disabilities, reported financial results for the third quarter ended September 30...
SAN DIEGO , Nov. 13, 2019 /PRNewswire/ -- Evofem Biosciences, Inc. (NASDAQ: EVFM), a clinical-stage biopharmaceutical company, announced today that Chief Executive Officer Saundra Pelletier will present at two upcoming healthcare equity conferences: Stifel's 2019 Healthc...
SAN JOSE, Calif. , Nov. 13, 2019 /PRNewswire/ -- Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of targeted immunotherapies using fully human monoclonal antibodies (mAbs) to treat life-threatening bacterial infectio...
TUCSON, Ariz. , Nov. 13, 2019 /PRNewswire/ -- AudioEye, Inc. (NASDAQ: AEYE), the leader in digital accessibility, has elected current shareholders and seasoned finance professionals David Moradi and Jamil Tahir to its board of directors, effective immediately. With t...
SAN FRANCISCO , Nov. 13, 2019 /PRNewswire/ -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage biotechnology company developing transformational treatments for patients with non-alcoholic steatohepatitis (NASH) and other serious metabolic disorders, today announced that...
MOUNTAIN VIEW, Calif. , Nov. 13, 2019 /PRNewswire/ -- Synopsys, Inc. (Nasdaq: SNPS) today announced it will report results for the fourth quarter and fiscal year 2019 on Wednesday, Dec. 4, 2019 , after the market close. A conference call to review the results will begin at 2:00 p.m...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
-7.66%Change Percent:
GeoVax Labs Inc. Company Name:
GOVX Stock Symbol:
OTCMKTS Market: